J. Márki-Zay

发表

Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias

Z. Janka, A. Juhász, Á. Rimanóczy, 2002, Molecular Psychiatry.

MDR-ABC transporters: biomarkers in rheumatoid arthritis.

J. Márki-Zay, P. Krajcsi, K. Tauberné Jakab, 2013, Clinical and experimental rheumatology.

Real-time PCR assay with fluorescent hybridization probes for exact and rapid genotyping of the angiotensin-converting enzyme gene insertion/deletion polymorphism.

J. Márki-Zay, F. Somogyvári, Z. Szolnoki, 2001, Clinical chemistry.

α 2-Macroglobulin exon 24 (Val-1000-Ile) polymorphism is not associated with late-onset sporadic Alzheimer's dementia in the Hungarian population

Z. Janka, A. Juhász, Á. Rimanóczy, 2002, Psychiatric genetics.

Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation

P. Reitsma, M. Neumaier, P. Corbisier, 2005, Clinical chemistry and laboratory medicine.

Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.

J. Márki-Zay, G. Paragh, A. Katona, 2006, Kardiologia polska.

Determination of Reference Values of MDR‐ABC Transporter Activities in CD3+ Lymphocytes of Healthy Volunteers Using a Flow Cytometry Based Method

J. Márki-Zay, Kata Filkor, G. Toldi, 2018, Cytometry. Part B, Clinical cytometry.

Effect of fenofibrate on Chlamydia pneumoniae antibody levels in patients with coronary artery disease.

J. Márki-Zay, A. Katona, L. Márk, 2002, The American journal of cardiology.

The nitric oxide synthase-3 codon 298 polymorphism is not associated with late-onset sporadic Alzheimer's dementia and Lewy body disease in a sample from Hungary

Z. Janka, É. Csibri, A. Palotás, 2003, Psychiatric genetics.

Amyloid peptides: The active center and the possible mechanism of action, starting and maintaining neuronal death

A. Baranyi, B. Penke, J. Márki-Zay, 1995 .

Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia.

Z. Janka, A. Juhász, J. Márki-Zay, 2000, Acta neurologica Scandinavica.

Certification of reference materials for detection of the human prothrombin gene G20210A sequence variant

P. Corbisier, J. Márki-Zay, C. Mannhalter, 2008, Clinical chemistry and laboratory medicine.

A new model for the development of Alzheimer’S disease

B. Penke, J. Márki-Zay, K. Soós, 1994 .

Synthesis and investigation of the β-amyloid 1–42 polypeptide and its analogs

B. Penke, J. Márki-Zay, M. Pákáski, 1993 .

[Schoenlein-Henoch purpura in adulthood (gastrointestinal manifestation and endoscopy)].

J. Márki-Zay, S. Sipka, A. Takats, 2001, Zeitschrift fur Gastroenterologie.

Lack of Influence of the Apolipoprotein E Genotype on the Outcome of Selegiline Treatment in Alzheimer’s Disease

Z. Janka, A. Palotás, A. Juhász, 2003, Dementia and Geriatric Cognitive Disorders.

European external quality control study on the competence of laboratories to recognize rare sequence variants resulting in unusual genotyping results.

C. Klein, J. Márki-Zay, H. Schimmel, 2009, Clinical chemistry.

Differential Sensitivity of the Species of Candida parapsilosis Sensu Lato Complex Against Statins

J. Márki-Zay, C. Vágvölgyi, A. Gácser, 2013, Mycopathologia.

Retrospective analyses of acenocoumarol doses and bleeding complications in patients with wild type or variant cytochrome P450 CYP2C9 alleles

J. Márki-Zay, G. Paragh, A. Katona, 2005, Thrombosis and Haemostasis.